Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.
Big, painful ERP migrations are fading, replaced by agentic SDLC that turns rigid integrations into adaptive, self-healing ...
NI LabVIEW+ Suite introduces code completion and other powerful capabilities to redefine test development productivity and ...
Early cancer detection through screening, mammography, MRI and advanced imaging is transforming outcomes, enabling timely ...
The pilot program — which drew a legal challenge from the hospital industry — would have required providers in the program to ...
DUBAI, United Arab Emirates, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The decentralized finance space continues to develop as more ...
Artificial intelligence promised to transform drug discovery but struggled to deliver. A new focus on validation and ...
Xiaomi is wrapping up the HyperOS 3.0 rollout and has already started focusing more on HyperOS 3.1. The upcoming HyperOS 3.1 ...
13hon MSN
Exclusive: Internal audit says Metro's microtransit program had long waits, limited oversight
The firm's report, obtained by the Houston Chronicle, reveals new details about the program's persistent challenges under ...
Through the development of its smart factory, SAEM has achieved a localization rate of over 80 percent for intelligent ...
StockStory.org on MSN
ESE Q4 deep dive: Aerospace, defense, and test businesses drive upward guidance
Engineered products manufacturer ESCO (NYSE:ESE) in Q4 CY2025, with sales up 17.3% year on year to $289.7 million. The ...
The FAA has certified the Emergency Autoland system for the HondaJet Elite II. It is the first twin-turbine jet in its class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results